Teva Announces Termination of Agreements with CureTech

News   Feb 01, 2013

 
Teva Announces Termination of Agreements with CureTech
 
 
 
 

RELATED ARTICLES

U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast Milk

News

The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.

READ MORE

Innate Reaction of Hematopoietic Stem Cells to Severe Infections

News

Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide, without signals from growth factors.

READ MORE

CRISPR Reveals New Targets for Promising Cancer Drugs

News

Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE